VEGFA and neoplasm: Cancerous cells reduce cytotoxic T lymphocyte (CTL) proliferation in the tumor by producing immunosuppressive cytokines such as interleukin (IL)-10, vascular endothelial growth factor (VEGF), and TGF- β and by consuming IL-2, a cytokine that plays a key role in maintaining CTL function [48].